Patent Monopolies Drive Record Profits
Novo Nordisk and Eli Lilly have transformed GLP-1 receptor agonists into unprecedented profit machines. These blockbuster drugs, approved for diabetes and weight loss, generate billions while leaving many patients unable…
Indianapolis-based pharmaceutical behemoth Eli Lilly has filed lawsuits against four compounders claiming that they sold unapproved products that contain tirzepatide, a key ingredient in the company’s weight-loss and diabetes drugs, including top-seller Mounjaro.The lawsuits against…
Continue Reading
Top News
Eli Lilly sues four telehealth startups — Mochi Health, Willow Health, Fella & Delilah Health, and Henry Meds — for selling compounded versions of its $1,000-per-month GLP-1 weight loss drug Zepbound.
The FDA…
What You Should Know:
– Eli Lilly and Company announced positive topline Phase 3 results from ACHIEVE-1, a study evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes…
Continue Reading
Diet weight loss company Noom entered into an agreement with Eli Lilly’s LillyDirect pharmacy provider Gifthealth to help improve access to FDA-approved Zepbound (tirzepatide) single-dose vials for Noom’s members with an on-label prescription from…
Continue Reading
Hybrid weight-inclusive primary and metabolic care provider knownwell announced it will be listed as a care provider on pharma giant Eli Lilly’s digital healthcare platform LillyDirect.knownwell touts itself as a hybrid weight-inclusive provider offering primary…
Continue Reading
What You Should Know:
– Noom, a digital healthcare company focused on chronic disease prevention and empowering healthy living announced an agreement with Gifthealth, the LillyDirect® pharmacy provider of Eli Lilly and Company.
– The collaboration…
Continue Reading
What You Should Know:
– Teladoc Health, the global leader in virtual care announced a partnership with Gifthealth, a digital pharmacy platform and partner of Eli Lilly’s LillyDirect program, to improve access to tirzepatide (brand…
Continue Reading
Andreessen Horowitz (a16z) Bio + Health announced it is partnering with pharma giant Eli Lilly and Company to form a new venture capital fund, dubbed the Biotech Ecosystem Venture Fund.The aim of the fund…
Continue Reading
Pharmaceutical powerhouse Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of Eli Lilly and Company, announced the creation of a SGD$42 million digital health innovation hub in Singapore.The…
Continue Reading
